{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:38:13Z","timestamp":1760060293215,"version":"build-2065373602"},"reference-count":70,"publisher":"MDPI AG","issue":"17","license":[{"start":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T00:00:00Z","timestamp":1756166400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>The interplay between angiogenesis and the immune system is intricate, with the potential to either enhance or repress the immune response. Angiogenesis-related genes (ARGs) are significant for the development, growth, and immune response of tumors. Understanding their prognostic significance and molecular characteristics in skin melanoma can guide and refine therapeutic strategies. Here, we analyzed the TCGA-SKCM dataset and explored the ARG expression between skin melanoma and normal skin, as well as between primary and metastatic tumors. Kaplan\u2013Meier analyses were conducted to assess the overall, disease-specific, and progression-free survival. Additionally, comprehensive immune profiling was carried out utilizing advanced bioinformatics tools to evaluate immune checkpoint gene expression and immune cell infiltration. Our findings highlighted strong prognostic associations for S100A4, ITGAV, and COL3A1. Molecular characterization showed a significant upregulation of PTK2, CXCL6, COL3A1, COL5A2, PF4, TNFRSF21, LRPAP1, VTN, TIMP1, SPP1, and OLR1 in SKCM compared to that in normal skin. Immune analyses, including Immune Checkpoint Gene Analysis, Immune Infiltration Analysis, Immune Cell Analysis, and Immune Cell Profiling, demonstrated both positive and negative correlations between ARGs expression and immune cell infiltration, emphasizing the multifaceted role of these genes in immune modulation. The study underscores the prognostic relevance of ARGs in skin melanoma and their contribution to tumor immunity. Overall, our findings expand our understanding of melanoma immunogenetics, suggesting the use of angiogenesis-related genes not merely as vascular regulators, but also as immune modulators.<\/jats:p>","DOI":"10.3390\/ijms26178254","type":"journal-article","created":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T14:43:18Z","timestamp":1756219398000},"page":"8254","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Angiogenesis-Related Genes Predict Outcomes and Immune Traits in Skin Melanoma"],"prefix":"10.3390","volume":"26","author":[{"given":"Latchezara","family":"Vladova","sequence":"first","affiliation":[{"name":"Department of Life Sciences, School of Sciences, European University Cyprus, Nicosia 1516, Cyprus"},{"name":"Cancer Genetics, Genomics and Systems Biology Laboratory, Basic and Translational Cancer Research Center (BTCRC), Nicosia 1516, Cyprus"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3641-1488","authenticated-orcid":false,"given":"Ilias","family":"Georgakopoulos-Soares","sequence":"additional","affiliation":[{"name":"Department of Life Sciences, School of Sciences, European University Cyprus, Nicosia 1516, Cyprus"},{"name":"Department of Biochemistry and Molecular Biology, Institute for Personalized Medicine, Penn State University College of Medicine, Hershey, PA 17033, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4625-5562","authenticated-orcid":false,"given":"Apostolos","family":"Zaravinos","sequence":"additional","affiliation":[{"name":"Department of Life Sciences, School of Sciences, European University Cyprus, Nicosia 1516, Cyprus"},{"name":"Cancer Genetics, Genomics and Systems Biology Laboratory, Basic and Translational Cancer Research Center (BTCRC), Nicosia 1516, Cyprus"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,8,26]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/nrc.2016.37","article-title":"From melanocytes to melanomas","volume":"16","author":"Shain","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/s41568-023-00565-7","article-title":"The journey from melanocytes to melanoma","volume":"23","author":"Centeno","year":"2023","journal-title":"Nat. Rev. Cancer"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1152\/physrev.00044.2003","article-title":"Melanin pigmentation in mammalian skin and its hormonal regulation","volume":"84","author":"Slominski","year":"2004","journal-title":"Physiol. Rev."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Slominski, R.M., Sarna, T., P\u0142onka, P.M., Raman, C., Bro\u017cyna, A.A., and Slominski, A.T. (2022). Melanoma, Melanin, and Melanogenesis: The Yin and Yang Relationship. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.842496"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Slominski, R.M., Kim, T.-K., Janjetovic, Z., Bro\u017cyna, A.A., Podgorska, E., Dixon, K.M., Mason, R.S., Tuckey, R.C., Sharma, R., and Crossman, D.K. (2024). Malignant Melanoma: An Overview, New Perspectives, and Vitamin D Signaling. Cancers, 16.","DOI":"10.3390\/cancers16122262"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Yang, K., Oak, A.S.W., Slominski, R.M., Bro\u017cyna, A.A., and Slominski, A.T. (2020). Current molecular markers of melanoma and treatment targets. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21103535"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Teixido, C., Castillo, P., Martinez-Vila, C., Arance, A., and Alos, L. (2021). Molecular markers and targets in melanoma. Cells, 10.","DOI":"10.3390\/cells10092320"},{"key":"ref_8","first-page":"1071","article-title":"Cutaneous melanoma: From pathogenesis to therapy (Review)","volume":"52","author":"Leonardi","year":"2018","journal-title":"Int. J. Oncol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.cpt.2024.08.002","article-title":"Overview of skin cancer types and prevalence rates across continents","volume":"3","author":"Roky","year":"2024","journal-title":"Cancer Pathog. Ther."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/CM9.0000000000003416","article-title":"Recent global patterns in skin cancer incidence, mortality, and prevalence","volume":"138","author":"Wang","year":"2025","journal-title":"Chin. Med. J."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/j.1365-2133.2007.08029.x","article-title":"Trends in melanoma epidemiology suggest three different types of melanoma","volume":"157","author":"Lipsker","year":"2007","journal-title":"Br. J. Dermatol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0140-6736(23)00821-8","article-title":"Cutaneous melanoma","volume":"402","author":"Long","year":"2023","journal-title":"Lancet"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"15003","DOI":"10.1038\/nrdp.2015.3","article-title":"Melanoma","volume":"1","author":"Schadendorf","year":"2015","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: The next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.semcancer.2009.05.003","article-title":"The angiogenic switch in carcinogenesis","volume":"19","author":"Baeriswyl","year":"2009","journal-title":"Semin. Cancer Biol."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Cazzato, G., Ingravallo, G., and Ribatti, D. (2024). Angiogenesis Still Plays a Crucial Role in Human Melanoma Progression. Cancers, 16.","DOI":"10.3390\/cancers16101794"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/jemt.10259","article-title":"Angiogenesis in cutaneous melanoma: Pathogenesis and clinical implications","volume":"60","author":"Srivastava","year":"2003","journal-title":"Microsc. Res. Tech."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.gde.2004.12.005","article-title":"Cellular abnormalities of blood vessels as targets in cancer","volume":"15","author":"Baluk","year":"2005","journal-title":"Curr. Opin. Genet. Dev."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1053\/j.seminoncol.2007.09.009","article-title":"Angiogenesis in Melanoma","volume":"34","author":"Mahabeleshwar","year":"2007","journal-title":"Semin. Oncol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"5449","DOI":"10.1158\/1078-0432.CCR-18-1543","article-title":"The intersection between tumor angiogenesis and immune suppression","volume":"25","author":"Rahma","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1002\/cncr.24975","article-title":"Disrupting established tumor blood vessels: An emerging therapeutic strategy for cancer","volume":"116","author":"McKeage","year":"2010","journal-title":"Cancer"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Simiczyjew, A., Dratkiewicz, E., Mazurkiewicz, J., Zi\u0119tek, M., Matkowski, R., and Nowak, D. (2020). The influence of tumor microenvironment on immune escape of melanoma. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21218359"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Falcone, I., Conciatori, F., Bazzichetto, C., Ferretti, G., Cognetti, F., Ciuffreda, L., and Milella, M. (2020). Tumor microenvironment: Implications in melanoma resistance to targeted therapy and immunotherapy. Cancers, 12.","DOI":"10.3390\/cancers12102870"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Li, C., Kuai, L., Cui, R., and Miao, X. (2022). Melanogenesis and the Targeted Therapy of Melanoma. Biomolecules, 12.","DOI":"10.3390\/biom12121874"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/s41392-021-00827-6","article-title":"Signal pathways of melanoma and targeted therapy","volume":"6","author":"Wang","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1136\/jclinpath-2015-203482","article-title":"Angiogenesis in melanoma: An update with a focus on current targeted therapies","volume":"69","author":"Jour","year":"2016","journal-title":"J. Clin. Pathol."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Zhou, X., Ni, Y., Liang, X., Lin, Y., An, B., He, X., and Zhao, X. (2022). Mechanisms of Tumor Resistance to Immune Checkpoint Blockade and Combination Strategies to Overcome Resistance. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.915094"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1177\/1947601909356574","article-title":"Mechanisms of Resistance to Anti-Angiogenic Therapy and Development of Third-Generation Anti-Angiogenic Drug Candidates","volume":"1","author":"Loges","year":"2010","journal-title":"Genes Cancer"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"3166","DOI":"10.1038\/s41388-018-0209-0","article-title":"Collagen Abundance Controls Melanoma Phenotypes through Lineage-Specific Microenvironment Sensing","volume":"37","author":"Miskolczi","year":"2018","journal-title":"Oncogene"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Nurzat, Y., Su, W., Min, P., Li, K., Xu, H., and Zhang, Y. (2021). Identification of Therapeutic Targets and Prognostic Biomarkers Among Integrin Subunits in the Skin Cutaneous Melanoma Microenvironment. Front. Oncol., 11.","DOI":"10.3389\/fonc.2021.751875"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/CMR.0000000000000512","article-title":"Expression and Clinical Significance of S100 Family Genes in Patients with Melanoma","volume":"29","author":"Xiong","year":"2019","journal-title":"Melanoma Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1002\/(SICI)1097-0215(19970822)74:4<464::AID-IJC19>3.0.CO;2-9","article-title":"Differential Expression Patterns of S100a2, S100a4 and S100a6 During Progression of Human Malignant Melanoma","volume":"74","author":"Maelandsmo","year":"1997","journal-title":"Int. J. Cancer"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1111\/j.1600-0625.2008.00779.x","article-title":"Immune Modulation by Melanoma-Derived Factors","volume":"17","author":"Ilkovitch","year":"2008","journal-title":"Exp. Dermatol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1038\/nrc909","article-title":"VEGF and the Quest for Tumour Angiogenesis Factors","volume":"2","author":"Ferrara","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/joim.12019","article-title":"VEGFA and Tumour Angiogenesis","volume":"273","author":"Welsh","year":"2013","journal-title":"J. Intern. Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"122563","DOI":"10.1016\/j.lfs.2024.122563","article-title":"VEGF\/VEGFR Axis and Its Signaling in Melanoma: Current Knowledge toward Therapeutic Targeting Agents and Future Perspectives","volume":"345","author":"Malekan","year":"2024","journal-title":"Life Sci."},{"key":"ref_37","first-page":"534","article-title":"The role of VEGF in melanoma progression","volume":"17","author":"Rajabi","year":"2012","journal-title":"J. Res. Med. Sci."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1161\/ATVBAHA.108.179663","article-title":"Vascular Endothelial Growth Factor","volume":"29","author":"Ferrara","year":"2009","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1177\/1947601911432334","article-title":"Molecular Mechanisms of Tumor Angiogenesis","volume":"2","author":"Ziyad","year":"2011","journal-title":"Genes Cancer"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"107179","DOI":"10.1016\/j.phrs.2024.107179","article-title":"Treating Cancer through Modulating Exosomal Protein Loading and Function: The Prospects of Natural Products and Traditional Chinese Medicine","volume":"203","author":"Meng","year":"2024","journal-title":"Pharmacol. Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"110492","DOI":"10.1016\/j.celrep.2022.110492","article-title":"Tumor-Derived Jagged1 Promotes Cancer Progression through Immune Evasion","volume":"38","author":"Meng","year":"2022","journal-title":"Cell Rep."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1053\/j.seminoncol.2011.01.004","article-title":"Molecular Profiling of Melanoma and the Evolution of Patient-Specific Therapy","volume":"38","author":"Gajewski","year":"2011","journal-title":"Semin. Oncol."},{"key":"ref_43","unstructured":"Liu, Y., Wang, L., Ngan, H.-L., and Lui, V.W.Y. (2020). Bioinformatics Tools and Validation Methods for Immune Infiltrates in Tumor Microenvironments and Immunogenomics. Recent Trends in Biotechnology, MedDocs International."},{"key":"ref_44","unstructured":"Desta, G.M., and Birhanu, A.G. (2025). Advancements in Single-Cell RNA Sequencing and Spatial Transcriptomics: Transforming Biomedical Research. Acta Biochim. Pol., 5."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"4413","DOI":"10.1007\/s10238-023-01152-8","article-title":"CXCL6: A Potential Therapeutic Target for Inflammation and Cancer","volume":"23","author":"Dai","year":"2023","journal-title":"Clin. Exp. Med."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"SenGupta, S., Hein, L.E., and Parent, C.A. (2021). The Recruitment of Neutrophils to the Tumor Microenvironment Is Regulated by Multiple Mediators. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.734188"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/978-3-030-55031-8_13","article-title":"Notch Pathway: A Journey from Notching Phenotypes to Cancer Immunotherapy","volume":"Volume 1287","author":"Monticone","year":"2021","journal-title":"Notch Signaling in Embryology and Cancer"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Wang, M., Yu, F., Zhang, Y., and Li, P. (2024). Novel Insights into Notch Signaling in Tumor Immunity: Potential Targets for Cancer Immunotherapy. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1352484"},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Li, D., Masiero, M., Banham, A.H., and Harris, A.L. (2014). The Notch Ligand Jagged1 as a Target for Anti-Tumour Therapy. Front. Oncol., 4.","DOI":"10.3389\/fonc.2014.00254"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1186\/s12957-020-02070-9","article-title":"Follistatin-like 1 (FSTL1) is a prognostic biomarker and correlated with immune cell infiltration in gastric cancer","volume":"18","author":"Li","year":"2020","journal-title":"World J. Surg. Oncol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"217400","DOI":"10.1016\/j.canlet.2024.217400","article-title":"FSTL1 Sustains Glioma Stem Cell Stemness and Promotes Immunosuppressive Macrophage Polarization in Glioblastoma","volume":"611","author":"Zhou","year":"2025","journal-title":"Cancer Lett."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Wasik, A., Ratajczak-Wielgomas, K., Badzinski, A., Dziegiel, P., and Podhorska-Okolow, M. (2022). The Role of Periostin in Angiogenesis and Lymphangiogenesis in Tumors. Cancers, 14.","DOI":"10.3390\/cancers14174225"},{"key":"ref_53","first-page":"252","article-title":"A Review of Mechanisms of Resistance to Immune Checkpoint Inhibitors and Potential Strategies for Therapy","volume":"3","author":"Fujiwara","year":"2020","journal-title":"Cancer Drug Resist."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Wu, Z., Liu, X., Yan, Z., Sun, Y., Zhang, M., and Lin, Y. (2022). The Role of Angiogenesis in Melanoma: Clinical Treatments and Future Expectations. Front. Pharmacol., 13.","DOI":"10.3389\/fphar.2022.1028647"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1007\/s00018-019-03351-7","article-title":"Tumor Angiogenesis: Causes, Consequences, Challenges and Opportunities","volume":"77","author":"Lugano","year":"2020","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Comunanza, V., and Bussolino, F. (2017). Therapy for Cancer: Strategy of Combining Anti-Angiogenic and Target Therapies. Front. Cell Dev. Biol., 5.","DOI":"10.3389\/fcell.2017.00101"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/pcmr.13125","article-title":"A Twenty Year Perspective on Melanoma Therapy","volume":"36","author":"Flaherty","year":"2023","journal-title":"Pigment Cell Melanoma Res."},{"key":"ref_58","first-page":"197","article-title":"Treatment of Cutaneous Melanoma: Current Approaches and Future Prospects","volume":"2","author":"Algazi","year":"2010","journal-title":"Cancer Manag. Res."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"77","DOI":"10.7555\/JBR.36.20210163","article-title":"Melanoma Therapeutics: A Literature Review","volume":"36","author":"Dhanyamraju","year":"2022","journal-title":"J. Biomed. Res."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.immuni.2018.03.023","article-title":"The immune landscape of cancer","volume":"48","author":"Thorsson","year":"2018","journal-title":"Immunity"},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"ICGC\/TCGA Pan-Cancer Analysis of Whole Genomes Consortium (2020). Pan-cancer analysis of whole genomes. Nature, 578, 82\u201393. Erratum in Nature\u00a02023, 614, E39. https:\/\/doi.org\/10.1038\/s41586-022-05598-w.","DOI":"10.1038\/s41586-022-05598-w"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nmeth.3337","article-title":"Robust enumeration of cell subsets from tissue expression profiles","volume":"12","author":"Newman","year":"2015","journal-title":"Nat. Methods"},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Aran, D., Hu, Z., and Butte, A.J. (2017). xCell: Digitally portraying the tissue cellular heterogeneity landscape. Genome Biol., 18.","DOI":"10.1186\/s13059-017-1349-1"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.1158\/0008-5472.CAN-17-0307","article-title":"TIMER: A web server for comprehensive analysis of tumor-infiltrating immune cells","volume":"77","author":"Li","year":"2017","journal-title":"Cancer Res."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Becht, E., Giraldo, N.A., Lacroix, L., Buttard, B., Elarouci, N., Petitprez, F., Selves, J., Laurent-Puig, P., Saut\u00e8s-Fridman, C., and Fridman, W.H. (2016). Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression. Genome Biol., 17, Erratum in Genome Biol.\u00a02016, 17, 249. https:\/\/doi.org\/10.1186\/s13059-016-1113-y.","DOI":"10.1186\/s13059-016-1113-y"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"e26476","DOI":"10.7554\/eLife.26476","article-title":"Simultaneous enumeration of cancer and immune cell types from bulk tumor gene expression data","volume":"6","author":"Racle","year":"2017","journal-title":"eLife"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13073-019-0638-6","article-title":"Molecular and pharmacological modulators of the tumor immune contexture revealed by deconvolution of RNA-seq data","volume":"11","author":"Finotello","year":"2019","journal-title":"Genome Med."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.celrep.2016.12.019","article-title":"Pan-cancer immunogenomic analyses reveal genotype-immunophenotype relationships and predictors of response to checkpoint blockade","volume":"18","author":"Charoentong","year":"2017","journal-title":"Cell Rep."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Zeng, D., Ye, Z., Shen, R., Yu, G., Wu, J., Xiong, Y., Zhou, R., Qiu, W., Huang, N., and Sun, L. (2021). IOBR: Multi-omics immuno-oncology biological research to decode tumor microenvironment and signatures. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.687975"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1214\/aos\/1176345976","article-title":"Cox\u2019s regression model for counting processes: A large sample study","volume":"10","author":"Andersen","year":"1982","journal-title":"Ann. Stat."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/17\/8254\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:32:54Z","timestamp":1760034774000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/17\/8254"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,26]]},"references-count":70,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["ijms26178254"],"URL":"https:\/\/doi.org\/10.3390\/ijms26178254","relation":{},"ISSN":["1422-0067"],"issn-type":[{"type":"electronic","value":"1422-0067"}],"subject":[],"published":{"date-parts":[[2025,8,26]]}}}